Cancer vaccines such as Dendreon Corp.'s Provenge (sipuleucel-T) harness dendritic cells to fight tumors. In fact, the discoverer of dendritic cells – Ralph Steinman, who in 2011 won the first posthumous Nobel Prize for his discovery – treated himself with therapies based on his own discovery after he was diagnosed with pancreatic cancer.